Civitas (CIVI) Alert: Johnson Fistel Investigates Proposed Sale of Civitas Solutions, Inc. to Centerbridge Partners, L.P.; Are Shareholders Getting a Fair Deal?
Civitas (CIVI) Alert: Johnson Fistel Investigates Proposed Sale of Civitas Solutions, Inc. to Centerbridge Partners, L.P.; Are Shareholders Getting a Fair Deal? |
[18-December-2018] |
SAN DIEGO, Dec. 18, 2018 /PRNewswire/ -- Shareholder rights law firm Johnson Fistel, LLP has launched an investigation into whether the board members of Civitas Solutions, Inc. (NYSE: CIVI) ("Civitas") breached their fiduciary duties in connection with the proposed sale of the Company to Centerbridge Partners, L.P. ("Centerbridge"). On December 18, 2018, Civitas announced that it had signed a definitive merger agreement with Centerbridge. Under the terms of the merger agreement, Centerbridge will acquire all outstanding shares of Civitas common stock for $17.75 in cash per share of Civitas common stock. The investigation concerns whether the Civitas board failed to satisfy its duties to the Company shareholders, including whether the board adequately pursued alternatives to the acquisition and whether the board obtained the best price possible for Civitas shares of common stock. Nationally recognized Johnson Fistel is investigating whether the proposed deal represents adequate consideration, especially given that one Wall Street analyst has a $20.00 price target on the stock, and analysts' projections for future earnings and revenue growth. If you are a shareholder of Civitas and believe the proposed buyout price is too low or you're interested in learning more about the investigation or your legal rights and remedies, please contact lead analyst Jim Baker (jimb@johnsonfistel.com) at 619-814-4471. If emailing, please include a phone number. Additionally, you can [Click here to join this action]. There is no cost or obligation to you. About Johnson Fistel, LLP: Contact: [Click here to join this action]
SOURCE Johnson Fistel, LLP | ||
Company Codes: NYSE:CIVI |
© 2018 PR Newswire. All Rights Reserved.